{"gao_id": "GAO-20-423", "published": "2020-05-26T12:00:00Z", "released": "2020-05-26T08:00:00Z", "summary": "The Bureau of Prisons provides a portfolio of drug education and treatment programs to help federal inmates with substance use disorders. In fiscal year 2019, the Bureau began treating inmates with opioid use disorder via a new medication-assisted treatment program. The Bureau is expanding this program, but hasn\u2019t documented how it will gauge the additional agency personnel needed, how it plans to recruit and onboard...", "title": "Bureau of Prisons: Improved Planning Would Help BOP Evaluate and Manage Its Portfolio of Drug Education and Treatment Programs", "topics": ["Drug education", "Addiction", "Justice and Law Enforcement", "Methadone", "Federal prisons", "Therapy", "Prescription drugs", "Psychology", "Drugs", "Substance abuse treatment", "Substance abuse"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-423", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-423-highlights.pdf"}, {"title": "Full Report (65 pages)", "url": "https://www.gao.gov/assets/gao-20-423.pdf"}, {"title": "Accessible PDF (70 pages)", "url": "https://www.gao.gov/assets/710/707169.pdf"}]}